|

RTN-001 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: SLx-2101

Pipeline

Phase 2: 1

Top Sponsors

  • Retension Pharmaceuticals. Inc.1

Indications

  • Uncontrolled Hypertension1
  • Heart Disease1

Monroe, North Carolina1 trial

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Retensiion Clinical Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.